A detailed history of Burleson & Company, LLC transactions in Danaher Corp stock. As of the latest transaction made, Burleson & Company, LLC holds 6,959 shares of DHR stock, worth $1.66 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
6,959
Previous 877 693.5%
Holding current value
$1.66 Million
Previous $227,000 713.66%
% of portfolio
0.48%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$241.42 - $282.29 $1.47 Million - $1.72 Million
6,082 Added 693.5%
6,959 $1.85 Million
Q3 2022

Oct 17, 2022

BUY
$247.06 - $1507.4 $169,483 - $1.03 Million
686 Added 359.16%
877 $227,000
Q2 2022

Jul 13, 2022

BUY
$237.11 - $299.66 $4,979 - $6,292
21 Added 12.35%
191 $48,000
Q1 2022

Apr 25, 2022

BUY
$257.27 - $315.76 $3,859 - $4,736
15 Added 9.68%
170 $50,000
Q2 2021

Jul 22, 2021

SELL
$225.08 - $271.69 $4,726 - $5,705
-21 Reduced 11.93%
155 $42,000
Q1 2021

May 12, 2021

BUY
$212.38 - $245.9 $37,378 - $43,278
176 New
176 $40,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.